نتایج جستجو برای: antineoplastic drugs

تعداد نتایج: 235269  

Journal: :The Canadian journal of hospital pharmacy 2011
Chun-Yip Hon George Astrakianakis Quinn Danyluk Winnie Chu

BACKGROUND It is believed that health care workers are exposed to antineoplastic drugs primarily via dermal contact. However, levels of occupational dermal contamination in Canada have not been formally investigated. OBJECTIVE To determine the potential dermal exposure to antineoplastic drugs among hospital pharmacy personnel in a metropolitan area in British Columbia. METHODS Six hospital ...

Journal: :Anticancer research 2012
Ignacio González-Sánchez Alfonso Lira-Rocha Andrés Navarrete Marco A Loza-Mejía Cristina Coronel-Cruz C Adriana Mendoza-Rodríguez Marco A Cerbón

BACKGROUND D3CLP (9-[(3-chloro)phenylamine]-2-[3-(diethylamine)propylamine]thiazolo[5,4-b]quinoline) is a potent cytotoxic thiazolo[5,4-b]quinoline synthetic derivative that induces apoptosis of leukemia cells, while it displays low toxicity towards non-tumoral cells. The aim of this study was to determine if D3CLP can enhance the cytotoxicity of other antineoplastic drugs. MATERIALS AND METH...

Journal: :International Journal of Pharmaceutical Sciences and Drug Research 2016

Journal: :American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2014
Carla Masini Oriana Nanni Sara Antaridi Davide Gallegati Mattia Marri Demis Paolucci Martina Minguzzi Mattia Altini

PURPOSE The quality and economic implications of manual versus automated preparation of antineoplastic drugs were compared. METHODS This four-week study evaluated 10 routinely used antineoplastic drugs (fluorouracil, cyclophosphamide, gemcitabine, trastuzumab, bevacizumab, oxaliplatin, cisplatin, paclitaxel, irinotecan, and etoposide) prepared by manual and automated procedures. The accuracy ...

Journal: :Cancer research 1995
G A Piazza A L Rahm M Krutzsch G Sperl N S Paranka P H Gross K Brendel R W Burt D S Alberts R Pamukcu

The nonsteroidal anti-inflammatory drug sulindac is known to inhibit chemical carcinogenesis in rodent models and cause regression of adenomas in patients with adenomatous polyposis coli. Sulindac is a prodrug that is metabolized to a pharmacologically active sulfide derivative that potently inhibits prostaglandin synthesis. Recent studies, however, have shown that a sulfone derivative of sulin...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید